Literature DB >> 23668404

Carvedilol.

Kevin Beattie1, Geeta Phadke, Jasmina Novakovic.   

Abstract

Carvedilol ((2RS)-1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]propan-2-ol), a β1-, β2-, and α1-adrenoreceptor blocker drug with antioxidant and antiproliferative effects, is indicated for treatment of hypertension, stable angina pectoris, and congestive heart failure. A profile of this drug substance is provided in this chapter and includes physical characteristics of Carvedilol (e.g., UV-vis, IR, NMR, and mass spectra). Details regarding the stability of Carvedilol in the solid state and solution phase are presented and methods of analysis (compendial and literature) are summarized. Furthermore, an account of the pharmacokinetics (ADME) and synthesis of Carvedilol are presented.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23668404     DOI: 10.1016/B978-0-12-407691-4.00004-6

Source DB:  PubMed          Journal:  Profiles Drug Subst Excip Relat Methodol        ISSN: 1871-5125


  7 in total

Review 1.  Novel treatment approaches in hypertensive type 2 diabetic patients.

Authors:  Yaniel Castro Torres; Richard E Katholi
Journal:  World J Diabetes       Date:  2014-08-15

2.  pH-Dependent Solubility and Dissolution Behavior of Carvedilol--Case Example of a Weakly Basic BCS Class II Drug.

Authors:  Rania Hamed; Areeg Awadallah; Suhair Sunoqrot; Ola Tarawneh; Sami Nazzal; Tamadur AlBaraghthi; Jihan Al Sayyad; Aiman Abbas
Journal:  AAPS PharmSciTech       Date:  2015-07-23       Impact factor: 3.246

3.  Impact of drying on dissolution behavior of carvedilol-loaded sustained release solid dispersion: development and characterization.

Authors:  Shimul Halder; Fairuza Ahmed; Madhabi Lata Shuma; M A K Azad; Eva Rahman Kabir
Journal:  Heliyon       Date:  2020-09-21

4.  Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro.

Authors:  Zhe Wang; Li Wang; Ren-Ai Xu; Yun-Yun Zhan; Cheng-Ke Huang; Da-Peng Dai; Jian-Ping Cai; Guo-Xin Hu
Journal:  Drug Des Devel Ther       Date:  2016-06-08       Impact factor: 4.162

5.  Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats.

Authors:  Ahmed Atwa; Rehab Hegazy; Nermeen Shaffie; Neamat Yassin; Sanaa Kenawy
Journal:  Open Access Maced J Med Sci       Date:  2016-08-01

6.  Formulation and Characterization of Acetazolamide/Carvedilol Niosomal Gel for Glaucoma Treatment: In Vitro, and In Vivo Study.

Authors:  Rehab Abdelmonem; Sammar F Elhabal; Nevine S Abdelmalak; Mohamed A El-Nabarawi; Mahmoud H Teaima
Journal:  Pharmaceutics       Date:  2021-02-05       Impact factor: 6.321

7.  Development of an Electrospun Patch Platform Technology for the Delivery of Carvedilol in the Oral Mucosa.

Authors:  Maria Pardo-Figuerez; Jorge Teno; Alvaro Lafraya; Cristina Prieto; Jose Maria Lagaron
Journal:  Nanomaterials (Basel)       Date:  2022-01-27       Impact factor: 5.076

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.